Published in Osteopath Med Prim Care on August 11, 2010
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease. Biomaterials (2014) 0.86
Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice. PLoS One (2016) 0.77
Progress on diabetic cerebrovascular diseases. Bosn J Basic Med Sci (2014) 0.77
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Peripheral arterial disease in people with diabetes. Diabetes Care (2003) 4.36
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA (1982) 4.25
Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care (2004) 4.17
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med (2001) 2.60
Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol (2006) 1.92
The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol (2007) 1.68
The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care (2004) 1.31
Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med (2006) 1.11
Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care (2007) 1.10
Hyperglycemia in acute stroke. Stroke (2004) 1.09
Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand (1987) 1.07
Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol (2008) 1.03
Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg (1990) 1.03
The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol (2003) 1.02
Obesity and the metabolic syndrome: the San Antonio Heart Study. Br J Nutr (2000) 0.94
A primary care approach to the patient with claudication. Am Fam Physician (2000) 0.89
The economic imperative to conquer diabetes. Diabetes Care (2008) 0.81
Contemporary management of peripheral arterial disease: III. Endovascular and surgical management. Cleve Clin J Med (2006) 0.80
Use of case-based reasoning to enhance intensive management of patients on insulin pump therapy. J Diabetes Sci Technol (2008) 1.26
Evaluating the automated blood glucose pattern detection and case-retrieval modules of the 4 Diabetes Support System. J Diabetes Sci Technol (2010) 1.05
Characterizing blood glucose variability using new metrics with continuous glucose monitoring data. J Diabetes Sci Technol (2011) 0.98
Type 2 diabetes mellitus: practical approaches for primary care physicians. J Am Osteopath Assoc (2011) 0.89
Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. J Diabetes Complications (2013) 0.88
A consensus perceived glycemic variability metric. J Diabetes Sci Technol (2013) 0.86
Racial disparities in African Americans with diabetes: process and outcome mismatch. Am J Manag Care (2012) 0.83
Diabetes care in extended-care facilities: appropriate intensity of care? Diabetes Care (2007) 0.82
Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections. J Diabetes Sci Technol (2012) 0.80
Diabetes numeracy and blood glucose control: association with type of diabetes and source of care. Clin Diabetes (2014) 0.79
Evaluation of diabetes management in a rural community hospital. Endocr Pract (2008) 0.79
Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Circ Cardiovasc Qual Outcomes (2014) 0.78
Use of and attitudes toward complementary and alternative medicine among osteopathic medical students. J Am Osteopath Assoc (2012) 0.78
How well are we managing diabetes in long-term care? J Fam Pract (2012) 0.78
Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Diabetes Care (2014) 0.76
Highlights From the American Diabetes Association's 2017 Standards of Medical Care in Diabetes for Osteopathic Physicians. J Am Osteopath Assoc (2017) 0.75
Evolution of "The Guideline Advantage": Lessons learned from the front lines of outpatient performance measurement. CA Cancer J Clin (2014) 0.75
Employer-Funded Complete Health Improvement Program: Preliminary Results of Biomarker Changes. J Am Osteopath Assoc (2017) 0.75
Diabetes management within evolving health care delivery models: the osteopathic perspective. J Am Osteopath Assoc (2015) 0.75
Inpatient osteopathic structural examinations: is "red tape" getting in the way of personalized patient care? J Am Osteopath Assoc (2008) 0.75
Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects. J Am Osteopath Assoc (2011) 0.75
Payer source influence on effectiveness of lifestyle medicine programs. Am J Manag Care (2015) 0.75
Vitamin D Deficiency, Its Role in Health and Disease, and Current Supplementation Recommendations. J Am Osteopath Assoc (2017) 0.75
Effects of Osteopathic Manipulative Treatment on Diabetic Gastroparesis. J Am Osteopath Assoc (2015) 0.75
Role of osteopathic structural diagnosis and osteopathic manipulative treatment for diabetes mellitus and its complications. J Am Osteopath Assoc (2013) 0.75
Be a "great physician" for your patients with type 2 diabetes mellitus. J Am Osteopath Assoc (2012) 0.75
Effectiveness of the Complete Health Improvement Program in Reducing Risk Factors for Cardiovascular Disease in an Appalachian Population. J Am Osteopath Assoc (2016) 0.75
Cardiovascular Disease Risk Factors After an Employer-Based Risk Reduction Program: An Observational Cohort Study. J Am Osteopath Assoc (2017) 0.75
Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform. J Am Osteopath Assoc (2015) 0.75
GLP-1 agonists: improving the future of patients with type 2 diabetes. J Am Osteopath Assoc (2011) 0.75
Glycated Hemoglobin Testing to Identify Undiagnosed Diabetes Mellitus in the Inpatient Setting. J Am Osteopath Assoc (2016) 0.75